Retesting BRCA1/BRCA2 mutation negative male breast cancer patients using next generation sequencing technologies

Breast Cancer Res Treat. 2017 Feb;162(1):199-200. doi: 10.1007/s10549-017-4108-9. Epub 2017 Jan 16.

Authors

Piera Rizzolo¹, Valentina Silvestri¹, Laura Ottini²

Affiliations

¹ Sapienza University of Rome, Rome, Italy.
² Sapienza University of Rome, Rome, Italy. [email protected].

PMID: 28091860
DOI: 10.1007/s10549-017-4108-9

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't
Comment

MeSH terms

BRCA2 Protein / genetics
Breast Neoplasms / genetics
Breast Neoplasms, Male / genetics*
Genes, BRCA1
Genes, BRCA2
Germ-Line Mutation
High-Throughput Nucleotide Sequencing*
Humans
Male
Mutation

Substances

BRCA2 Protein